Ascentage Pharma SVP Discloses Initial Holdings of ~362k Shares
ASCENTAGE PHARMA GROUP INTERNATIONAL
Subscribe to track AAPG
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
Ascentage Pharma SVP Discloses Initial Holdings of ~362k Shares
Company: ASCENTAGE PHARMA GROUP INTERNATIONAL (AAPG) Form: 3 (Initial Statement) | Filed: 2026-03-23 Significance: Low
Insider: Knapp Thomas J Title: SVP/General Counsel | Relationship: Officer
Holdings Reported: • Common Stock: 362,444 shares (Direct) • Options: 38,938 shares (Strike $8.14, Exp 2035) • RSUs: 38,938 shares
Key Insight: New initial disclosure of beneficial ownership by the General Counsel. Total common stock holdings represent <0.1% of the company's $16.35B market cap.
Market Context: Ascentage Pharma is a large-cap ($16.35B) pharmaceutical company. This filing establishes the baseline ownership for this officer.
Comprehensive Analysis
SEC Filing Analysis: ASCENTAGE PHARMA GROUP INTERNATIONAL (AAPG)
Executive Summary
- Trading Significance: Low
- Key Takeaway: SVP/General Counsel Thomas J. Knapp files initial statement of beneficial ownership disclosing ~362k direct shares and additional derivative incentives.
- Market Impact: Neutral; this is a compliance filing establishing baseline ownership rather than a market-moving trade.
Company Information
| Field | Value |
|---|---|
| Company | ASCENTAGE PHARMA GROUP INTERNATIONAL |
| Ticker Symbol | AAPG |
| CIK | 0002023311 |
| Industry | Pharmaceutical Preparations |
Insider Information
| Field | Value |
|---|---|
| Name | Knapp Thomas J |
| CIK | 0001311726 |
| Title/Position | SVP/General Counsel |
| Relationship | Officer |
Transaction Details
| Field | Value |
|---|---|
| Form Type | 3 (Initial Statement of Beneficial Ownership) |
| Transaction Date | 2026-03-18 |
| Security Type | Ordinary Shares |
| Shares Reported | 362,444 |
| Ownership Type | Direct |
Financial Impact Assessment
Transaction Materiality
| Metric | Value |
|---|---|
| Implied Share Price | ~$43.80 (Derived from Market Cap) |
| Est. Holdings Value | ~$15.87 Million |
| % of Market Cap | ~0.097% |
| Shares Reported | 362,444 |
| % of Shares Outstanding | ~0.097% |
| Materiality Assessment | Low |
Impact Evaluation
- Market Cap Context: For a $16.35 billion company, a $15M holding is substantial for an individual but represents less than 0.1% of the company's total value.
- Ownership Concentration: The insider holds approximately 0.097% of the 373.32M shares outstanding, indicating a standard executive equity position rather than a controlling stake.
- Derivatives: The filer also disclosed 38,938 stock options (exercise price $8.14) and 38,938 RSUs, both vesting over a 4-year period starting in 2026.
Market Impact Analysis
Stock Impact Prediction
- Direction: Neutral
- Reasoning: Form 3 filings are administrative requirements for new insiders or newly public companies. While it shows alignment of interest via equity ownership, it does not represent immediate buying pressure.
Volume & Sentiment
- Expected Volume Impact: Negligible.
- Sentiment Indicator: Neutral.
Additional Context
- Footnotes: The exercise price for options is denominated in HKD and converted to USD ($8.14). Vesting for both Options and RSUs occurs in equal increments from 2026 through 2029.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.